| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 17.61% | Argus Research | → $171 | Upgrades | Hold → Buy |
| 11/02/2023 | 14.17% | Bernstein | $189 → $166 | Downgrades | Outperform → Market Perform |
| 10/26/2023 | 10.04% | Susquehanna | $197 → $160 | Downgrades | Positive → Neutral |
| 10/24/2023 | 17.61% | Wells Fargo | $170 → $171 | Downgrades | Overweight → Equal-Weight |
| 10/24/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 10/18/2023 | 12.1% | Citigroup | $155 → $163 | Maintains | Neutral |
| 10/18/2023 | 35.49% | Susquehanna | $187 → $197 | Maintains | Positive |
| 10/18/2023 | 32.74% | Raymond James | $166 → $193 | Maintains | Outperform |
| 10/17/2023 | 13.48% | Morgan Stanley | $166 → $165 | Maintains | Overweight |
| 10/09/2023 | 16.23% | Piper Sandler | $167 → $169 | Maintains | Overweight |
| 10/04/2023 | 44.43% | UBS | $206 → $210 | Maintains | Buy |
| 10/02/2023 | 14.17% | Morgan Stanley | $158 → $166 | Maintains | Overweight |
| 09/18/2023 | 22.42% | Mizuho | $175 → $178 | Maintains | Neutral |
| 08/18/2023 | 8.67% | Morgan Stanley | $154 → $158 | Maintains | Overweight |
| 08/17/2023 | 41.68% | UBS | $168 → $206 | Maintains | Buy |
| 08/16/2023 | 20.36% | Mizuho | $169 → $175 | Maintains | Neutral |
| 08/02/2023 | 6.6% | Citigroup | $152 → $155 | Maintains | Neutral |
| 07/24/2023 | 14.17% | Raymond James | $172 → $166 | Maintains | Outperform |
| 07/21/2023 | 25.86% | Susquehanna | $185 → $183 | Maintains | Positive |
| 07/18/2023 | 5.91% | Morgan Stanley | $158 → $154 | Maintains | Overweight |
| 07/11/2023 | 4.54% | Citigroup | $159 → $152 | Maintains | Neutral |
| 06/13/2023 | 12.79% | Piper Sandler | $168 → $164 | Maintains | Overweight |
| 05/19/2023 | 15.54% | Mizuho | $170 → $168 | Maintains | Neutral |
| 05/18/2023 | 15.54% | Piper Sandler | $167 → $168 | Maintains | Overweight |
| 05/15/2023 | 8.67% | Morgan Stanley | $156 → $158 | Maintains | Overweight |
| 04/28/2023 | 9.35% | Citigroup | $153 → $159 | Maintains | Neutral |
| 04/21/2023 | 18.29% | Raymond James | $170 → $172 | Maintains | Outperform |
| 04/20/2023 | 14.86% | Piper Sandler | $166 → $167 | Maintains | Overweight |
| 04/19/2023 | 26.55% | UBS | → $184 | Assumes | → Buy |
| 04/13/2023 | 7.29% | Morgan Stanley | $139 → $156 | Maintains | Overweight |
| 04/05/2023 | 8.67% | JP Morgan | $156 → $158 | Maintains | Overweight |
| 03/27/2023 | -4.4% | Morgan Stanley | $130 → $139 | Maintains | Overweight |
| 03/24/2023 | -7.84% | Goldman Sachs | $170 → $134 | Maintains | Neutral |
| 03/10/2023 | 16.92% | Mizuho | $163 → $170 | Maintains | Neutral |
| 03/10/2023 | 16.92% | Raymond James | $175 → $170 | Maintains | Outperform |
| 01/27/2023 | 10.04% | Citigroup | $155 → $160 | Maintains | Neutral |
| 01/27/2023 | 16.92% | Goldman Sachs | $161 → $170 | Downgrades | Buy → Neutral |
| 01/26/2023 | 37.55% | B of A Securities | $185 → $200 | Maintains | Buy |
| 01/26/2023 | 16.92% | Wells Fargo | $162 → $170 | Maintains | Overweight |
| 01/26/2023 | 3.16% | Credit Suisse | $125 → $150 | Maintains | Neutral |
| 01/25/2023 | 12.1% | Mizuho | $164 → $163 | Maintains | Neutral |
| 01/23/2023 | 10.04% | Barclays | $155 → $160 | Maintains | Overweight |
| 01/23/2023 | 20.36% | Raymond James | $160 → $175 | Maintains | Outperform |
| 01/19/2023 | -10.59% | Morgan Stanley | $123 → $130 | Maintains | Overweight |
| 01/12/2023 | 24.48% | Wolfe Research | → $181 | Upgrades | Peer Perform → Outperform |
| 01/10/2023 | 11.42% | Wells Fargo | $159 → $162 | Maintains | Overweight |
| 01/10/2023 | 12.79% | Mizuho | $150 → $164 | Downgrades | Buy → Neutral |
| 12/19/2022 | 7.29% | Piper Sandler | $164 → $156 | Maintains | Overweight |
| 12/07/2022 | 6.6% | Barclays | $145 → $155 | Maintains | Overweight |
| 11/11/2022 | 12.79% | Piper Sandler | $155 → $164 | Maintains | Overweight |
| 10/24/2022 | 3.16% | Mizuho | $143 → $150 | Maintains | Buy |
| 10/19/2022 | -15.41% | Morgan Stanley | $134 → $123 | Maintains | Overweight |
| 10/19/2022 | -0.28% | Barclays | $146 → $145 | Maintains | Overweight |
| 10/19/2022 | -3.71% | Jefferies | → $140 | Initiates Coverage On | → Hold |
| 10/04/2022 | 0.41% | JP Morgan | $149 → $146 | Maintains | Overweight |
| 09/21/2022 | -10.59% | Citigroup | $110 → $130 | Maintains | Neutral |
| 08/31/2022 | 0.41% | Barclays | $149 → $146 | Maintains | Overweight |
| 08/31/2022 | -3.71% | Raymond James | $130 → $140 | Maintains | Outperform |
| 08/29/2022 | -7.84% | Morgan Stanley | $135 → $134 | Maintains | Overweight |
| 07/26/2022 | -10.59% | Raymond James | $140 → $130 | Maintains | Outperform |
| 07/19/2022 | -7.15% | Morgan Stanley | $141 → $135 | Maintains | Overweight |
| 07/19/2022 | 10.04% | B of A Securities | $180 → $160 | Maintains | Buy |
| 07/19/2022 | -1.65% | Mizuho | $158 → $143 | Maintains | Buy |
| 07/19/2022 | 13.48% | Piper Sandler | $161 → $165 | Maintains | Overweight |
| 07/15/2022 | 2.48% | Barclays | $153 → $149 | Maintains | Overweight |
| 06/24/2022 | — | Citigroup | Downgrades | Buy → Neutral | |
| 06/14/2022 | 5.23% | Barclays | $131 → $153 | Maintains | Overweight |
| 06/06/2022 | -3.03% | Morgan Stanley | $137 → $141 | Maintains | Overweight |
| 05/31/2022 | 8.67% | Mizuho | $139 → $158 | Maintains | Buy |
| 04/28/2022 | -7.15% | Wells Fargo | $133 → $135 | Maintains | Overweight |
| 04/25/2022 | -5.09% | Susquehanna | $118 → $138 | Maintains | Positive |
| 04/25/2022 | -3.71% | Raymond James | $112 → $140 | Maintains | Outperform |
| 04/22/2022 | -5.78% | Morgan Stanley | $121 → $137 | Maintains | Overweight |
| 04/12/2022 | -9.9% | Barclays | $124 → $131 | Maintains | Overweight |
| 03/31/2022 | -4.4% | Mizuho | $132 → $139 | Maintains | Buy |
| 03/11/2022 | -8.53% | Wells Fargo | $106 → $133 | Maintains | Overweight |
| 01/27/2022 | -39.48% | Credit Suisse | $86 → $88 | Maintains | Neutral |
| 01/25/2022 | -16.78% | Morgan Stanley | $114 → $121 | Maintains | Overweight |
| 01/11/2022 | -27.79% | Barclays | $106 → $105 | Maintains | Overweight |
| 12/13/2021 | -21.6% | Morgan Stanley | $117 → $114 | Maintains | Overweight |
| 11/30/2021 | -9.22% | Mizuho | $130 → $132 | Maintains | Buy |
| 11/19/2021 | -19.53% | Morgan Stanley | $115 → $117 | Maintains | Overweight |
| 10/26/2021 | -22.97% | Raymond James | $95 → $112 | Maintains | Outperform |
| 10/06/2021 | -20.91% | Morgan Stanley | $111 → $115 | Maintains | Overweight |
| 07/29/2021 | -42.23% | Credit Suisse | $82 → $84 | Maintains | Neutral |
| 07/15/2021 | -20.22% | Mizuho | $112 → $116 | Maintains | Buy |
| 06/30/2021 | -28.47% | Wells Fargo | $98 → $104 | Maintains | Overweight |
| 06/21/2021 | -17.47% | Bernstein | $91 → $120 | Maintains | Outperform |
| 06/18/2021 | -23.66% | Morgan Stanley | $86 → $111 | Maintains | Overweight |
| 06/11/2021 | -31.22% | JP Morgan | $80 → $100 | Maintains | Overweight |
| 06/03/2021 | -37.41% | Barclays | $81 → $91 | Maintains | Overweight |
| 06/01/2021 | -32.6% | Wells Fargo | $86 → $98 | Maintains | Overweight |
| 05/19/2021 | -40.85% | Morgan Stanley | $82 → $86 | Maintains | Overweight |
| 05/17/2021 | -22.97% | Mizuho | $94 → $112 | Maintains | Buy |
| 04/01/2021 | -40.85% | Piper Sandler | $69 → $86 | Maintains | Overweight |
| 03/31/2021 | -35.35% | Mizuho | $76 → $94 | Upgrades | Neutral → Buy |
| 03/23/2021 | -42.23% | Citigroup | $72 → $84 | Maintains | Buy |
| 03/11/2021 | -43.6% | Morgan Stanley | $64 → $82 | Maintains | Overweight |
| 09/28/2020 | -56.67% | B of A Securities | $70 → $63 | Maintains | Buy |
| 09/24/2020 | — | Scotiabank | Downgrades | Sector Outperform → Sector Perform | |
| 08/21/2020 | -60.8% | Morgan Stanley | $49 → $57 | Maintains | Overweight |
| 07/24/2020 | -55.98% | Piper Sandler | $50 → $64 | Maintains | Overweight |
| 07/20/2020 | -62.17% | Raymond James | $52 → $55 | Maintains | Outperform |
| 07/15/2020 | -59.42% | Wolfe Research | $53 → $59 | Upgrades | Peer Perform → Outperform |
| 07/13/2020 | -58.73% | Scotiabank | $65 → $60 | Maintains | Sector Outperform |
| 06/29/2020 | -66.3% | UBS | $37 → $49 | Maintains | Neutral |
| 06/02/2020 | -58.73% | Citigroup | $46 → $60 | Upgrades | Neutral → Buy |
| 06/01/2020 | -63.55% | JP Morgan | $37 → $53 | Upgrades | Neutral → Overweight |
| 05/19/2020 | -66.3% | Morgan Stanley | $48 → $49 | Maintains | Overweight |
| 05/08/2020 | -68.36% | Credit Suisse | $40 → $46 | Maintains | Neutral |
| 04/29/2020 | -68.36% | Citigroup | $34 → $46 | Maintains | Neutral |
| 04/28/2020 | -69.05% | Mizuho | $39 → $45 | Maintains | Neutral |
| 04/03/2020 | -60.8% | Wells Fargo | $59 → $57 | Maintains | Overweight |
| 03/31/2020 | -74.55% | UBS | $60 → $37 | Maintains | Neutral |
| 03/20/2020 | -59.42% | Wells Fargo | $83 → $59 | Maintains | Overweight |
| 03/20/2020 | -76.62% | Citigroup | $39 → $34 | Maintains | Neutral |
| 03/16/2020 | -66.99% | Morgan Stanley | $82 → $48 | Maintains | Overweight |
| 03/16/2020 | -65.61% | Goldman Sachs | → $50 | Upgrades | Neutral → Buy |
| 03/16/2020 | -67.68% | BMO Capital | $70 → $47 | Upgrades | Market Perform → Outperform |
| 02/28/2020 | -47.04% | B of A Securities | $80 → $77 | Maintains | Buy |
| 02/03/2020 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 01/30/2020 | -45.67% | Scotiabank | → $79 | Upgrades | Sector Underperform → Sector Outperform |
| 01/24/2020 | -48.42% | Raymond James | $70 → $75 | Maintains | Outperform |
| 01/14/2020 | -43.6% | Susquehanna | → $82 | Initiates Coverage On | → Positive |
| 12/10/2019 | -55.3% | JP Morgan | → $65 | Upgrades | Underweight → Neutral |
| 12/05/2019 | -55.3% | Cowen & Co. | → $65 | Initiates Coverage On | → Market Perform |
| 11/13/2019 | — | Scotiabank | Downgrades | Sector Outperform → Sector Underperform | |
| 11/04/2019 | -50.48% | Morgan Stanley | $71 → $72 | Maintains | Overweight |
| 10/07/2019 | -44.98% | B of A Securities | $75 → $80 | Reiterates | → Buy |
| 09/23/2019 | -51.86% | Citigroup | → $70 | Initiates Coverage On | → Neutral |
| 08/19/2019 | -36.04% | Barclays | → $93 | Initiates Coverage On | → Overweight |
| 05/28/2019 | — | MKM Partners | Upgrades | Neutral → Buy | |
| 05/15/2019 | — | Capital One | Upgrades | Underweight → Equal-Weight | |
| 04/16/2019 | — | MKM Partners | Downgrades | Buy → Neutral | |
| 01/10/2019 | -54.61% | Barclays | → $66 | Upgrades | Equal-Weight → Overweight |
| 11/20/2018 | -45.67% | Morgan Stanley | $91 → $79 | Maintains | Overweight |
What is the target price for Hess (HES)?
The latest price target for Hess (NYSE: HES) was reported by Argus Research on November 7, 2023. The analyst firm set a price target for $171.00 expecting HES to rise to within 12 months (a possible 17.61% upside). 50 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hess (HES)?
The latest analyst rating for Hess (NYSE: HES) was provided by Argus Research, and Hess upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Hess (HES)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hess, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hess was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Hess (HES) correct?
While ratings are subjective and will change, the latest Hess (HES) rating was a upgraded with a price target of $0.00 to $171.00. The current price Hess (HES) is trading at is $145.40, which is within the analyst's predicted range.